Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q4 2025 Earnings Call Transcript February 26, 2026
Intellia Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.83, expectations were $-0.99.
Operator: Hello, and welcome to Intellia Therapeutics, Inc.’s fourth quarter and full year 2025 conference call. My name is Drew, and I will be your conference operator today. Please be advised that today’s call is being recorded. I will now turn the call over to Jason Fredette, Vice President...
